Although both the complement and contact system are thought to contribute to the inflammatory reaction in arthritic joints, only activation of complement has so far been well established, whereas contact activation and its contribution to arthritis has not been systematically explored. Complement and contact activation were assessed in 71 patients with inflammatory arthropathies and 11 with osteoarthritis using sensitive assays for C3a, and Cl-inhibitor (CIINH)-kallikrein and ClINH-factor XIIa complexes respectively.
krein-and factor XUa-CIINH complexes were found in two and seven of the 71 patients with inflammatory arthropathies, respectively, and in none of the patients with osteoarthritis. Increased synovial fluid concentrations of kallikrein and factor XIIa complexes occurred in 13 and 15 patients with inflammatory joint diseases respectively, and in two patients with osteoarthritis. Contact system parameters did not correlate with clinical symptoms, local activity, or neutrophil activation.
In contrast, synovial fluid concentrations of C3a and CIINH-Cl complexes were increased in all patients and in 20 patients with inflammatory arthropathies respectively, and were higher in patients with a higher local activity score. Synovial fluid C3a correlated with parameters of neutrophil activation such as lactoferrin. Increased plasma concentrations of C3a and CIINH-Cl complexes occurred in 13 and 11 patients with inflammatory joint diseases, and in one and two patients with osteoarthritis respectively. Plasma concentrations of C3a correlated with the number of painful joints.
Thus contact activation occurs only sporadically in patients with arthritis and contributes little if anything to the local inflammatory reaction and neutrophil activation. These latter events are significantly related to the extent of complement activation.
(Ann Rheum Dis 1992; 51: [1123] [1124] [1125] [1126] [1127] [1128] Neutrophils are the predominant cells present in the synovial cavity ofpatients with rheumatoid arthritis (RA) and gout. ' 2 The presence of increased concentrations of elastase, lactoferrin, and other neutrophil granule constituents in arthritic joints suggests that these cells are activated. 3 4 Activation of the complement and the contact system results in the production of factors that are chemotactic or agonistic, or both, for neutrophils in vitro (for review, see Vogt' and Kaplan6) . Evidence for complement activation in arthritic joints is abundant. For example, increased concentrations of split products of the third component of the complement system, C3, in joints of patients with RA and gout have often been reported. 7 11 Intra-articular complement activation has also been shown to correlate with leucocyte levels. 1-13
The contact system of coagulation is also thought to contribute to the inflammatory response observed in arthritis (for reviews, see Kaplan6 and Cochrane and Griffin '4 or to serum to which aggregated IgG was added29 (containing 360 nM ClINH-Cl complexes). Plasma and synovial fluid concentrations ofcomplexes in patients were considered to be increased when they exceeded the mean +2SD of the plasma concentrations in 28 healthy volunteers, i.e.> 0 19 nM for ClINHfactor XIIa, > 0 85 nM of ClINH-kallikrein, and > 18 nM for ClINH-Cl complexes.
Concentrations of C3a, prekallikrein, factor XII, functional CIINH, and total CIINH in plasma and synovial fluid were determined by radioimmunoassay as described previously.23 24 (In plasma, and presumably also in synovial fluid, C3a is rapidly converted to C3adesarg. In this paper we use C3a to designate both C3a and C3adesarg.) C5a did not differ between patient groups, whereas total concentrations of prekallikrein were higher in synovial fluid from patients with inflammatory joint diseases compared with osteoarthritis (p<005, table 1). The percentage of complexed kallikrein and factor XII, i.e. the concentration of complexes compared with the total concentration of prekallikrein/kallikrein and factor XII respectively, was 0-08 and 0-04% in plasma, and 0-21 and 0 09% in synovial fluid, and was significantly higher in synovial fluid than in plasma (p<0 00001 for CIINHkallikrein and CIINH-factor XIIa complexes). Synovial fluid concentrations of total and inactivated C1INH were higher in patients with inflammatory joint diseases compared with osteoarthritis (p<0 001 for both, table 2). When the amount of inactivated CIINH was expressed as a fraction of total C1INH, however, no significant difference was found between these patient groups (p=0 370). Also the functional index of C1INH, i.e. the ratio of functional/antigenic C1INH, did not differ significantly between patient groups. None of the contact system parameters correlated with local activity of the joints.
CONTACT ACTIVATION IN PLASMA
In plasma from 71 patients with arthritis, we occasionally found increased concentrations of ClINH complexes (table 2) . Six patients (five with RA and one with gout) had increased CIINH-factor XIIa complexes (i.e. >0 19 nM) and three patients (all with RA) had increased CIINH-kallikrein complexes (i.e. >0 85 nM). In two of 28 volunteers we also found increased concentrations of C lINH-kallikrein and ClINH-factor XIIa complexes. Concentrations of total, functional, and inactivated CIINH in plasma from patients with inflammatory joint diseases were significantly higher than in plasma from patients with osteoarthritis and healthy volunteers. The fraction of inactivated CIINH In 42 patients we also measured CSa concentrations. In 25 patients with RA mean (SD) plasma concentrations were 5-1 (3-4) nglml whereas synovial fluid concentrations were 14 (11-4) ng/ml. In three patients with gout these concentrations were 4-3 (3 2) and 4-3 (1-5), in nine patients with seronegative spondyloarthropathies 5.9 (2-4) and 6-6 (4-5), and in five patients with osteoarthritis 3.9 (2-1) and 4-3 (3-2) respectively. C3a and C5a concentrations correlated with each other (r=0 74; p< l0-7), with ClINH-Cl complexes (r=0 78 and r=0-71 with p< 10-6 for both), and with levels of inactivated C1INH (r=0-67 and r=0-62 with p<l0-4 for both). C3a and C5a concentrations also correlated with parameters of neutrophil activation such as lactoferrin (r=0-58 and r=0-67 with p<10-8 for both) (table 4). In 48 patients (37 with RA, three with gout, and eight with seronegative spondylarthritis) the local activity of the aspirated joint was clinically assessed. When patients were divided into two approximately equal groups according to their score for local activity, we found that patients with a higher local activity score (median score in these patients was 6, range 5-8) had higher concentrations ofC3a and ClINH-Cl complexes (p<005) than patients with a lower score (median 3, range 2-4) (fig 2) . In 71 patients with inflammatory arthropathies, plasma concentrations of C3a and Cl-CIINH were higher than in 28 healthy controls (p= 0-006 and p<00001, respectively) ( 42 The absence of any relation between ClINH-kallikrein complexes or other contact system parameters and neutrophil parameters suggests that this phenomenon does not have a pathogenetic role in arthritis.
In conclusion, in arthritic joints the contact system was activated only in occasional patients. In contrast, activation of the complement system was a general finding in arthritic joints, and appears to be responsible for the local inflammatory reaction and the influx and activation of neutrophils in arthritis.
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